Article Text

Download PDFPDF
  1. Paul Glasziou

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    How convincing does the evidence need to be before we change practice? If we shift too early, then we risk giving patients useless or even harmful treatments, such as flecainide, hormone replacement therapy, and cox-2 inhibitors. But if we shift late then we (temporarily) deny the benefits of breakthroughs to our patients. Achieving …

    View Full Text